Figure 1. The formulation of spherical nucleic acid nanoparticle conjugates (SNA-NCs)

siRNA-based nanoparticle constructs are formed by covalently linking therapeutic siRNAs to the surface of spherical gold nanoparticles that are approximately 13 nm in diameter